Focal cortical dysplasias (FCDs) are local malformations of the human neocortex with strong epileptogenic potential. To investigate the underlying pathomechanisms, we performed a whole human transcriptome screening to compare the gene expression pattern of dysplastic versus nondysplastic temporal neocortex. Tissue obtained from FCD IIIa cases (mean age 20.5 years) who had undergone surgical treatment, due to intractable epilepsy, was compared with nondysplastic specimens (mean age 19.9 years) by means of Affymetrix arrays covering 28 869 genes. We found 211 differentially expressed genes (DEX) among which mainly genes important for oligodendrocyte differentiation and myelination were downregulated in FCD IIIa. These findings were confirmed as functionally important by Database for Annotation, Visualization, and Integrated Discovery (DAVID) analysis. The reduced expression of myelin-associated transcripts was confirmed for FCD Ia, IIa, and IIIa by real-time RT-qPCR. In addition, we found that the density of myelin basic protein mRNA-expressing oligodendrocytes and of 2′,3′-cyclic nucleotide 3′-phosphodiesterase-positive myelin fibers was significantly reduced in dysplastic cortex. Moreover, high-resolution confocal imaging and 3D reconstruction revealed that the myelin fiber network was severely disorganized in dysplastic neocortex, indicating a disturbance of myelin sheath formation and maintenance in FCD.
Introduction
Focal malformations of the human neocortex, in particular focal cortical dysplasias (FCDs) , are identified in 20-25% of patients with focal epilepsies (Kuzniecky et al. 1993) , which are a frequent cause of pharmacoresistance, especially in children, and are associated with high seizure frequencies (Palmini et al. 1991; Fauser et al. 2004 Fauser et al. , 2006 . FCDs are increasingly diagnosed in epilepsy patients owing to improved imaging techniques (Palmini et al. 1991; Chan et al. 1998; Bastos et al. 1999; Kassubek et al. 2002; Wilke et al. 2003; Huppertz et al. 2005) . Neurosurgical resection of the dysplastic lesion frequently results in a seizure-free clinical outcome (Fauser et al. 2004; Hauptman and Mathern 2012; Leach et al. 2014; Fauser et al. 2015) . FCDs are characterized by local architectural disturbances of the six-layered neocortex, including dyslamination or hypercolumnization of neurons and the presence of dysmorphic neurons or balloon cells. These features have been used in the FCD classification of Palmini et al. (2004) , which has been extended recently by distinguishing isolated FCD from FCD types associated with other principal lesions (Blumcke et al. 2011) . Isolated forms can be located in all brain lobi and are assumed to originate from disturbed cortical development (Barkovich and Kuzniecky 1996) , whereas lesionassociated FCDs are predominantly found in the temporal lobe and are thought to be acquired from epileptic lesions such as Ammon's horn sclerosis (AHS); (Blumcke et al. 2011) . Presurgical diagnosis by conventional magnetic resonance imaging (MRI) techniques is only reliable for high-grade FCD (IIa and IIb) due to features such as blurring of the gray-white matter boundary, hypomyelination in the white matter (Blumcke et al. 2011) , as well as a funnel shape formation through the white matter (Urbach et al. 2002; Hofman et al. 2011; Hauptman and Mathern 2012) .
Although FCD is a common cause of epilepsy, there is sparse knowledge about the underlying pathomechanisms. So far, different approaches for studying morphological and molecular aspects of dysplastic tissue have been chosen. One prominent technique is the application of layer-specific markers as a histological tool to investigate cortical layering and cellular composition (Hadjivassiliou et al. 2010; Rossini et al. 2011; Arai et al. 2012; Sakakibara et al. 2012; Fauser et al. 2013 ). Besides, several array studies were published recently investigating the molecular mechanisms underlying FCD or intractable temporal lobe epilepsy, but all these reports had limitations such as small patient groups and/or small numbers of screened genes (Kim et al. 2003; Jamali et al. 2006; Xi et al. 2009 ), whereas others focused only on gene expression patterns of neuronal subtypes (Crino et al. 2001; Taylor et al. 2001; Hua and Crino 2003; Ljungberg et al. 2006) . There is new evidence that sporadic somatic mutations in the MTOR gene can result in FCD II (Lim et al. 2015) .
In the present study, we compared the gene expression pattern of adult FCD IIIa cases with nondysplastic controls originating all from the temporal lobe by microarray analysis covering the whole human transcriptome. We found 211 genes to be differentially expressed (DEX) in FCD IIIa. Among those, in particular, genes regulating oligodendrocyte differentiation and myelin sheath formation were downregulated. We show, by real-time RT-qPCR, that the downregulation of myelin-associated genes is a feature also present in isolated FCD types (Ia and IIa). Morphologically, the myelination deficit manifests itself in these FCD types by a reduced density of myelin basic protein (MBP) mRNA-expressing oligodendrocytes in the dysplastic cortex. Moreover, we present evidence by confocal laser microscopy and 3D reconstruction that myelin fibers are heavily disorganized in FCD.
Materials and Methods

Patient Selection
A total of 19 freshly dissected specimens from patients with FCD Ia, IIa, or IIIa and 8 epileptic, but non-dysplastic controls [approach tissue from tumor resections (WHO grade I)] were included in this study (Table 1 ). All specimens were derived from the temporal lobe (Brodmann areas 20, 21, 22, 38, 41, and 42) and were collected during surgery to allow optimal tissue preservation (for details, see Supplementary Fig. 1 ).
For the transcriptome screening, the following specimens were used: FCD IIIa [n = 6; mean age 20.5 years (range 6.9-35.5 years), mean epilepsy duration: 11.9 years (range 3.9-23 years)] and controls [n = 7; mean age: 19.9 years (range 15.3-27.4 years), mean epilepsy duration: 8.2 years (range 1-17.4 years)].
For real-time RT-qPCR, the following specimens were used: FCD Ia [n = 4; mean age: 20.2 years (range 12.5-33.5 years), mean epilepsy duration: 6.7 years (range 1.2-16.5 years)]; FCD IIa [n = 6; mean age: 22.9 years (range 8.7-36.3 years), mean epilepsy duration: 12.1 years (range 4-27.5 years)]; FCD IIIa [n = 9; (6 already analyzed by microarray screening), mean age: 18.5 years (range 6.9-36.5 years), mean epilepsy duration: 12.2 years (range 3.9-23 years)]; and epileptic, nondysplastic controls [n = 8; (7 already analyzed by microarray screening), mean age: 19.4 years (range 15.3-27.4 years), mean epilepsy duration: 7.5 years (range 1-10 years)].
For morphological analysis, 4 cases/groups were selected. All these cases had been already analyzed by microarrays (FCD IIIa and controls) and by real-time RT-qPCR (FCD IIIa; IIa, Ia, and controls). These cases had the following characteristics: FCD Ia [mean age: 20.2 years (range 12.5-33.5 years), mean epilepsy duration: 6.7 years (range 1. All FCD patients and control cases had undergone neurosurgical interventions due to pharmacoresistant epilepsy or low-grade tumors. In all patients, removal of cortical tissue was clinically warranted to achieve seizure or tumor control. Presurgical assessment included the documentation of a detailed history, neurological examination, neuropsychological testing, MRI scanning, and noninvasive/invasive, long-term video EEG monitoring. Informed consent was obtained from patients and controls according to the Declaration of Helsinki. The Ethics Committee at the University Medical Center Freiburg approved the selection process and procedures.
For histopathological diagnosis, all specimens were classified on paraffin sections by the Department of Neuropathology (University Medical Center Freiburg) according to Blumcke et al. (2011) . In FCD IIIa cases, AHS was graded in resected hippocampus specimens according to Wyler et al. (1992) .
Tissue Preparation
All cortical specimens were collected immediately during surgery and immersed in ice-cold artificial cerebrospinal fluid containing (in mM): 87 NaCl, 25 NaHCO 3 , 2.5 KCl, 1.25 Na 2 HPO 4 , 10 glucose, 75 sucrose, 7 MgCl 2 , and 0.5 CaCl 2 . To allow a simultaneous morphological and molecular analysis of each specimen, slices of about 2-5 mm thickness were cut perpendicular to the brain surface. Adjacent slices were either 1) immersed in 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4, for 24-48 h at 4°C, and cryoprotected in 30% sucrose in PB or 2) were immediately snap-frozen in liquid nitrogen and stored at −80°C until processing for RNA preparation (see Supplementary Fig. 1 ).
For morphological analysis, cryostat sections (50 µm, orthogonal to the cortical surface) were prepared, collected in tissue culture dishes, and either rinsed in PB for immunohistochemistry (IHC) or in 2× SSC (1× SSC = 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0) for in situ hybridization histochemistry (ISHH).
RNA Extraction and Microarray Analysis
For the transcriptome screening, total RNA was isolated exclusively from the gray matter of FCD IIIa (n = 6) and non-dysplastic epilepsy cases (n = 7). To this end, frozen specimens were thawed on ice, the white matter was carefully removed with a scalpel in a solution containing 70% ammonium sulfate, 25 mM sodium citrate, and 10 mM ethylenediaminetetraacetic acid pH 5.2. The neocortex (30 mg/case) was lysed and homogenized, and total RNA was prepared by the RNeasy Mini Kit (QIAGEN). RNA integrity was determined by an Agilent 2100 Bioanalyzer (Agilent Technologies) and the RNA 6000 Nano Kit (Agilent) according to the manufacturer's instructions. Total RNA samples (400 ng each, RNA integrity number ≥7) were reversely transcribed into cDNA, in vitro transcribed into anti-sense cRNA, and again converted into sense cDNA with the Ambion WT Expression Kit (Ambion) as described by the manufacturer. The sense-strand cDNAs were fragmented and then end-labeled with biotin using the Affymetrix Terminal Labeling Kit (Affymetrix). Labeled fragments were hybridized to Affymetrix WT Human Gene ST 1.0 arrays (one array/patient or control, in total 13 arrays) for 16 h at 45°C and 60 rpm in an Affymetrix hybridization oven 645. After washing and staining using the hybridization, wash, and stain Kit (Affymetrix), the arrays were scanned with an Affymetrix GeneChip Scanner 3000 7G resulting in signal intensity values for each individual probe. Next, CIMFast Event Language files (CEL files) representing rasters of intensity values for all individual probes were generated from the raw data with the Affymetrix "GeneChip Command Console" Software (version 3.0.1).
We used the "Genedata Expressionist" software (Affymetrix) for further data analysis. CEL files were imported into the "Refiner" module of Expressionist (version 7.0) with which GC background subtraction was performed using anti-genomic background probes. Subsequently, quantile normalization and probe summarization were conducted using the "Bioconductor Robust Multi-Array Average" (RMA) condensing algorithm (Irizarry et al. 2003) . Further analysis was carried out with the "Analyst module" (version 7.0) of "Genedata Expressionist". Statistical calculation of principal component analysis (PCA) and of single gene expression rates was performed with "Partek ® Genomic Suite" software (Partek INC). Since on the microarrays each transcript was represented by several oligomers, the median was calculated for all measured fluorescence values covering one transcript and used for statistical analysis (one-way ANOVA). The fold change threshold for differential expression was set at ≥1.5 and P ≤ 0.05.
Functional Analysis of DEX Using Database for Annotation, Visualization and Integrated Discovery
The Database for Annotation, Visualization and Integrated Discovery (DAVID; version 6.7) is a set of web-based functional annotation tools (Dennis et al. 2003) . We used the "gene name batch viewer", the "functional annotation chart", and the "functional annotation clustering" tools as described by da Huang et al. (2009) to search for functional enrichment of the DEX (over-or underexpressed >1.5-fold in FCD IIIa) identified by microarray analysis. First, a list of official gene symbols of the 211 DEX (see Supplementary  Table 1 ) was uploaded via the web interface, and the background for enrichment analysis was selected as Homo sapiens. Second, we generated a gene list with the "gene name batch viewer" tool which displays all gene names. Third, we applied the "functional annotation chart" tool to identify enriched annotation terms associated with the DEX. Finally, the "functional annotation clustering" tool was used under highest stringency selection to cluster functionally similar terms associated with the DEX.
Reverse Transcription and Real-Time RT-qPCR Analysis
Reverse transcription was performed in the presence of 1 µg total RNA (RNA integrity values 7-10) using the Maxima First Strand cDNA Synthesis Kit (Fermentas) based on random decamer and oligo d(T) priming.
The expression of mRNAs (see below) was quantified by realtime RT-qPCR on a "MyiQ" Real-Time PCR Detection System (BioRad Laboratories) in the presence of SYBR Green (Applied Biosystems). The following human-specific primer pairs were used at 70 nM: S12 (mitochondrial ribosomal protein S12; forward 5′-AGTTGGTGGAGGCCCTTTGT-3′, reverse 5′-AGGCCTACCCA TTCTCCTAGTTTC-3′), myelin-associated glycoprotein (MAG; forward 5′-CAACTGAGTCCAAGTTGTCT-3′, reverse 5′-ATTCTG TACAGCGAGTGAGT-3′), MBP (forward 5′-AATTACTCACCGAG ACACAC-3′, reverse 5′-GAAGGATATGGTCAGAAGAG-3′), myelin oligodendrocyte glycoprotein (MOG; forward 5′-CTTCGAGCAG AGATAGAGAA-3′, reverse 5′-TCGATGTAGCCAGTTGTAG-3′), myelin regulatory factor (MYRF; forward 5′-CTACCACATCCCTG TCAGT-3′, reverse 5′-GGAGGAGGAGTTCATCTG-3′), CNP (forward 5′-ACACACAGCTTCTAGTGATTT-3′, reverse 5′-ACAGAGAAGCG AGTTCAG-3′), and oligodendrocytic myelin paranodal and inner loop protein (Opalin; forward 5′-CATGGAGGAAAGTG ACAG-3′, reverse 5′-CTCCCATCGTATTCTTCTC-3′). The cDNAs were applied in a dilution of 1 : 50. Cycling conditions were as follows: 15 min at 95°C followed by 50 cycles of 15 s at 95°C and 1 min at 60°C. Melting curves of the amplified products were used to control for specificity of the amplification reaction. The resulting fluorescence values (obtained by the "iQTM5 Optical System" Software) were background subtracted for exposure time, background fluorescence, and well factors yielding individual relative fluorescence units (RFUs), which represent amplification traces of every amplicon and every cycle.
RFUs were further corrected by the "Cy0 method", a tool for accurate and precise quantification of expression rates (Guescini et al. 2008 ). This method does not require the assumption of equal reaction efficiency between PCR reactions and provides consistent PCR data by plotting a Richard's curve obtained by the nonlinear regression of raw data. Following Cy0 correction, the ΔCT (cycle threshold) method was applied to calculate relative expression levels for genes of interest by normalization to the housekeeping gene S12, which encodes the ribosomal protein S12. Statistical analysis was performed with "GraphPad Prism 4" software (GraphPad Prism 4.02, GraphPad Software, Inc.). For multiple comparisons, a one-way ANOVA with Tukey's post hoc test was performed. Significance level was set at P ≤ 0.05.
In Situ Hybridization Histochemistry
Digoxigenin (DIG)-labeled anti-sense or sense riboprobes specific for MBP mRNA were generated by in vitro transcription from a pBluescript KS II + vector containing a 1.2-kb MBP cDNA (Schaeren-Wiemers and Gerfin-Moser 1993). ISHH was performed as described previously (Fauser et al. 2013) . In brief, cryostat sections (50 µm) were hybridized with DIG-labeled anti-sense or sense MBP cRNA probes (100 ng/mL) at 55°C overnight followed by several washing steps at 65°C. DIG-labeled hybrids were detected with an anti-DIG antibody from sheep conjugated with alkaline phosphatase as recommended by the manufacturer (Roche). For signal detection, nitrobluetetrazolium and 5-bromo-4-chloro-3-indolylphosphate were applied. The reaction was developed in the dark for 1 h. Finally, sections were coverslipped and mounted in Kaiser's gelatin.
Quantification of MBP mRNA-Expressing Cells in FCD and Control Tissue
ISHH sections were analyzed using bright field microscopy. Photomicrographs of cortical sections processed for MBP ISHH were taken and imported into "ImageJ" software (National Institutes of Health, Bethesda, MD, USA). MBP mRNA-positive cells were counted using the integrated "Cell Counter" plugin. For quantification, one representative cortical section/case (controls: n = 3; FCD n = 5) was selected. Cells were counted manually in 2 regions of interest (ROI)/section covering the 6 cortical layers. All MBP mRNA-positive oligodendrocytes were marked manually within each ROI, counted and the density was calculated using the area of the ROI (values are given in cells/mm 2 ). Groups were compared by unpaired Student's t-test using "GraphPad Prism 4" software. Significance level was set at P ≤ 0.05.
Immunohistochemistry
Cryosections (50 µm) were immunolabeled using a free-floating protocol as described earlier (Fauser et al. 2013) . After preincubation [0.25% Triton X-100, 10% normal serum (NS) in PB, 30 min] followed by overnight incubation at room temperature or at 4°C in 0.1% Triton X-100 and 1% NS with the following primary antibodies: Mouse monoclonal anti-SMI32 (specific for nonphosphorylated Neurofilament H, 1 : 1000; Covance), mouse monoclonal anti-NeuN (Neuronal Nuclei, 1 : 1000; Millipore), and rabbit monoclonal anti-CNPase (2′,3′-cyclic nucleotide 3′-phosphodiesterase, 1 : 100; Cell Signaling Technology). Antibody binding was visualized by incubation with appropriate secondary antibodies conjugated with cyanine-3 (Cy-3; 1 : 400; Jackson ImmunoResearch Laboratories) in the dark (3 h, at room temperature). Sections were mounted and coverslipped with IMMU-Mount (ThermoShandon). Sections were analyzed with a microscope equipped with appropriate fluorescence filters (Axioplan 2, Zeiss); photomicrographs were taken with a digital camera and processed with Axiovision software (Zeiss).
For double immunolabeling, tissue sections were pretreated as described above. Incubation with the 2 primary antibodies was performed sequentially as well as the exposure to the secondary antibodies: First, rabbit monoclonal anti-CNPase (1 : 100; Cell Signaling Technology) was applied overnight at 4°C followed by incubation with Cy-3-conjugated-F(ab′) 2 goat anti-rabbit fragments (1 : 200; Jackson ImmunoResearch Laboratories) for 3 h at room temperature. After washing in PB, the tissue sections were incubated with a rabbit monoclonal anti-MAG (1 : 100; Cell Signaling Technology) overnight at 4°C and immersed in Cy-2-conjugated goat anti-rabbit antibody (1 : 200; Jackson ImmunoResearch Laboratories) and 4′,6-diamidino-2-phenylindole (DAPI; 1 : 10 000; Roche) for 3 h at room temperature. Finally, sections were mounted and coverslipped with ProLong ® Gold Antifade Mountant (Invitrogen).
Confocal Microscopy, Image Processing, and 3D-Reconstruction of Myelin Fibers
We investigated the expression and arrangement of 2 major myelin-associated proteins (CNPase and MAG) using high-resolution confocal laser scanning microscopy. For each patient, we analyzed 3 double-labeled brain sections and acquired 3 z-stacks/ section at ×600 magnification (oil-immersion objective, N/A 1.35) with a "Fluoview FV10i" confocal microscope (Olympus).
The following parameters were applied for image acquisition: 1024 × 1024 image size; 4× average; 0.5 µm z-step size; 1 airy confocal aperture. Laser power and detector sensitivity were adjusted for controls to avoid blooming and was then kept constant for all scans. Acquired z-stacks were transferred to "Imaris 7.7.1" (Bitplane) for further analysis. Optical density was assessed for fluorescent signals of CNPase and MAG labeling. Next, we quantified the total volume and the number of individual volumes by using the "surface reconstruction" tool. First, the images were smoothed using a Gaussian filter (0.207 µm window size) and then the baseline signal was thresholded at 275 for CNPase and at 300 for MAG to reduce the background. Subsequently, we defined an ROI of 200 × 200 × 20 µm 3 in which the respective signals for CNPase and MAG were automatically reconstructed. The following parameters were used for surface reconstruction: Surface-smoothing with 0.1 µm detail; 0.75 µm sphere diameter; automatic threshold for local contrast; no further thresholds were applied. Subsequent to 3D reconstruction, the total volume and the number of reconstructed volumes were obtained from "Imaris" statistics.
Results
Morphological Characterization of Dysplastic and Control Specimens Used in This Study
Since FCD can be variable in extent and dimensions, we characterized every resected specimen destined for this study on the morphological level regarding lamination pattern and cytoarchitecture to determine the FCD type according to the ILAE classification system (Blumcke et al. 2011) . To this end, serial sections were stained with cresyl violet, immunolabeled for NeuN to visualize neurons of all layers (L), and for SMI32, a monoclonal antibody against non-phosphorylated neurofilament H (Sternberger and Sternberger 1983) , which specifically labels pyramidal cells of L III and V. In Figure 1 , representative sections of the different FCD types used in our study are shown. Cortical control specimens display a clearly defined sixlayered structure (Fig. 1A-C) . Pyramidal neurons are located in layers III and V, with parallel orientated apical dendrites which reach the border of layer I (Fig. 1D) . Layer IV appears as a gap between the 2 SMI32-labeled laminae, indicating that L IV is free of pyramidal cells (Fig. 1E) .
The characteristic feature of FCD Ia is an abnormal radial lamination (Blumcke et al. 2011) . Accordingly, Nissl and NeuN staining clearly show many tightly aligned, radial columns of neurons (hypercolumnization), especially detectable in L IV (Fig. 1F-H) . However, the six-layered pattern of cortical architecture is preserved and the layers are clearly distinguishable. Accordingly, SMI32-positive pyramidal neurons are located in L III and V with a parallel orientation of shortened apical dendrites that reach only the border of L II (Fig. 1I,J) .
FCD IIa is characterized by the presence of dysmorphic neurons (Palmini et al. 2004; Blumcke et al. 2011) . NeuN labeling reveals all 6 cortical layers in FCD IIa. Beyond that, a striking hypercolumnization reaching from L III to the white matter boundary is noticeable (Fig. 1K-M) . SMI32 labeling shows drastically shortened apical dendrites of pyramidal cells in L III and V (Fig. 1N,O) and many strongly stained, misorientated dysmorphic neurons in L III (Fig. 1O) .
In FCD IIIa, hexalamination is basically maintained (Fig. 1P,Q) , but a blurring of L II and III is noticeable (Fig. 1R) . In addition, SMI32 staining reveals a shortening of apical dendrites and an invasion of L V pyramidal cells into L IV (Fig. 1S,T) .
Transcriptome Screening Reveals FCD-Related Differential Gene Expression
For gene expression profiling, total RNA was isolated from human dysplastic temporal neocortex from patients with FCD IIIa and from non-dysplastic specimens (controls), converted into sense cDNA, and hybridized to expression microarrays covering 28 869 transcripts each.
The expression values obtained for each individual patient or control were first analyzed by PCA that allows to structure and condense multidimensional data sets. Furthermore, PCA can identify clustering patterns or outliers in our samples. PCA showed an overall variation of 49.4% for the 2 groups with 3 principle components (PC; PC1: 25.3%; PC2: 13.9%, and PC3: 10.2%), revealing that the gene expression profile was 1) heterogeneous within both groups and 2) FCD IIIa and controls overlapped due to high variability (see Supplementary Fig. 2A ). The individual data points of both groups were distributed over all 3 dimensions without cluster formation indicating strong heterogeneity. This was also reflected by the high false discovery rates obtained for the transcriptome analysis (see Supplementary Table 1) .
Next, we compared the 2 groups on the level of individual genes. To this end, all expression data were subjected to a oneway ANOVA with differential gene expression being defined as ≥1.5 fold change and P ≤ 0.05. We found clear differences in the gene expression pattern between dysplastic versus nondysplastic tissue: 211 (DEX) genes, excluding Y and X chromosomal located transcripts, were differentially expressed in dysplastic temporal neocortex when compared with controls. Remarkably, the majority of DEX (171 genes) was downregulated in comparison with epileptic, non-dysplastic neocortex with a fold change ranging from −1.50 to −4.49 (see Supplementary Table 1 ). Many of these downregulated transcripts encode proteins important for oligodendrocyte differentiation or myelin sheath formation and maintenance, such as gelsolin (GSN), CNP, gliomedin (GLDN), myelin and lymphocyte protein (MAL), myelin-associated oligodendrocyte basic protein (MOBP), UDP glycosyltransferase 8 (UGT8), aspartoacylase (ASPA), Opalin, MOG, Ermin, ERM-like protein (ERMN), and claudin 11 (CLDN11). Moreover, the expression of genes involved in cell signaling, cell adhesion, lipid/phospholipid metabolism, axon guidance/ensheathment/ development, and actin-cytoskeleton association was reduced in FCD IIIa when compared with controls (see Supplementary  Table 1 ).
In addition, we identified 40 upregulated transcripts with a fold change ranging from 2.79 to 1.50 in FCD IIIa. These transcripts encode proteins with various functions such as cell adhesion and signaling, for example ion and sugar transport, or are components of the ribosome. Also many pseudogenes or transcripts with unknown function were up-regulated (see Supplementary Table 1 ).
Functional Association Analysis of DEX
To identify the biological features of the 211 DEX, we used the DAVID bioinformatics resource which is able to systematically extract and map the biological context of a large number of genes (Dennis et al. 2003; da Huang et al. 2009 ). First, a gene list with the corresponding gene names of the uploaded gene symbols was generated for the 211 DEX (see Supplementary Table 1 and Supplementary Material-excel spreadsheet). Next, a functional annotation chart was created, which contained the most relevant biological annotation terms associated with the 211 DEX. We found the following enriched annotation terms with the corresponding genes in our DEX group: axon and neuron ensheathment (C11ORF9, MAL, and CLDN11), cell adhesion (PCDHB18, CDH19, CDH1, PCDHB13, PCDH7, and PCDHB11), synaptogenesis (CDH1, PCDHB13, PCDHB11, and CACNA1A), and regulation of action potential (C11ORF9, MAL, and CLDN11; see Supplementary Material-excel spreadsheet). Finally, we performed functional annotation clustering under the highest classification stringency and identified 37 annotation clusters for the 211 DEX (see Supplementary Material-excel spreadsheet). The top clusters with a high enrichment score contained annotation terms for biological processes such as homophilic cell adhesion (PCDHB18, CDH19, CDH1, PCDHB13, PCDH7, and PCDHB11), protein translation (MRPL24, SNORA7B, RPS27, RPS29, RPL13A, RPS21, and RPS24), synaptogenesis (CDH1, PCDHB13, PCDHB11, and CACNA1A), and axon and neuron ensheathment (C11ORF9, MAL, and CLDN11). Clustered annotation terms for cellular components included annotations like ribosome (SNORA7B, RPS27, RPS29, RPL13A, RPS21, and RPS24), tight junction (CNKSR3, CLDN11, and TJP2), and synapse (ARC, SYT9, SV2C, and SHC4). Annotation clusters for molecular functions were, for example, voltage-gated channel activity (CACNA1G, KCNJ2, and CACNA1A) or ATPase activity (ABCA8, ATP6V0C, and ATP10) (see Supplementary Material-excel spreadsheet).
Like the one-way ANOVA, the DAVID analysis detected axon and neuron ensheathment as biological process being affected in FCD. Hence, we focused our further investigations on this functional aspect and extended the analysis to isolated FCD types (Ia and IIa).
Validation of Differential Gene Expression by Real-Time RT-qPCR
To substantiate the results of the transcriptome screening and the DAVID analysis, we focused on 3 myelin-associated genes (MOG, CNP, and Opalin), differentially regulated in FCD IIIa, and 3 additional well known myelin components (MAG, MBP, and MYRF). We performed real-time RT-qPCR with the same RNA samples used for our microarray screening. In addition, samples of FCD Ia and IIa, both from the temporal lobe, were included in the analysis (for sample selection, see Table 1 ).
The expression levels of 5 analyzed transcripts were significantly down-regulated when all FCD cases were pooled and compared with the control group: MBP 17.7%, MOG 22.5%, MAG 18.4%, Opalin 14.6%, and MYRF 24.1% ( percent of control; Fig. 2) . We also found a strong down-regulation (ca. 50% or less) of all analyzed transcripts in FCD IIIa, Ia, and IIa, when they were individually compared with the control group (Fig. 2) . Remarkably, the isolated FCD types (Ia and IIa) revealed a stronger down-regulation of the analyzed transcripts than FCD IIIa (except for CNP). Specifically, FCD IIa presented with a significant down-regulation of MAG, MOG, MBP, Opalin, and MYRF, whereas FCD Ia reached significance for Opalin and MYRF, and FCD IIIa for MYRF and MAG (Fig. 2) .
In summary, the RT-qPCR analysis confirmed the significant down-regulation of MOG and Opalin mRNAs seen in the microarray analysis and additionally found the levels of MAG, MBP, and MYRF mRNA to be significantly lower in FCD Ia, IIa, and IIIa when compared with controls.
Altered Myelination Pattern in FCD Ia, IIa, and IIIa
Our next aim was to investigate whether the reduced expression of myelin-associated proteins was mirrored by abnormalities in the cortical myelination pattern. To this end, we performed ISHH for MBP mRNA, which is exclusively expressed in mature, myelinating oligodendrocytes (Cahoy et al. 2008) , and immunostaining for CNPase, a myelin-associated enzyme and marker for CNS myelin (Baumann and Pham-Dinh 2001; Shepherd et al. 2013 ) on tissue sections of dysplastic (FCD Ia, IIa, and IIIa) and of control cortex. In controls, the density of MBP mRNA-expressing oligodendrocytes was highest in the infragranular layers and decreased gradually up to L I (Fig. 3A) . MBP mRNA-positive cells appeared as single cells or were arranged in small columns or clusters (Fig. 3B,  I ). In FCD Ia, the density of MBP mRNA-expressing oligodendrocytes was reduced compared with the nondysplastic cortex (Fig. 3C,D,J,M) , with single cell more intensely stained than in control tissue (Fig. 3J) . Similarly, in FCD IIa, only a few isolated oligodendrocytes with faint MBP mRNA signals could be detected in the deeper cortical layers (Fig. 3E,F,K) . Accordingly, in FCD IIIa, MBP mRNA-positive oligodendrocytes were significantly thinned out across the entire cortex (Fig. 3G,H,L,N) as revealed by cell counting. Immunolabeling for CNPase revealed a strongly altered distribution of myelinated fiber bundles in FCD tissue when compared with non-dysplastic cortex. In the control case, a dense, radially aligned network of CNPase-positive fibers spread from the graywhite matter boundary up to layer IV (Fig. 4A,E) . In contrast, the signal intensity of these CNPase-immunolabeled fibers was strongly reduced in layers VI to IV of FCD Ia, IIa, and IIIa specimens (Fig. 4B-D,F-H) . In FCD IIa, the reduction of the CNPasepositive fibers was most pronounced (Fig. 4C,G) .
In summary, all 3 FCD types displayed deficits in myelination reflected by a decreased density of MBP mRNA-synthesizing oligodendrocytes and of CNPase-positive fibers in the gray matter.
Quantitative Confocal Analysis and 3D-reconstruction of Myelin Fibers in FCD Ia, IIa, and IIIa Next, we compared the arrangement of CNPase-and MAGimmunolabeled myelin fibers in control and FCD tissue by high-resolution confocal laser scanning microscopy and subsequent 3D reconstruction. For this analysis, we focused on L V (Fig. 5, upper right) , since there axons show a higher myelin coverage and are more homogeneously myelinated than those in L II and III, as shown recently in the adult neocortex by Tomassy et al. (2014) .
In controls, CNPase and MAG-positive fiber bundles were parallel aligned in L V (Fig. 5A) , whereas in FCD CNPase and MAG labeling was attenuated and appeared strongly disorganized (Fig. 5C,E,G) . Accordingly, we found by densitometry that CNPase and MAG immunolabeling was significantly reduced in FCD ( Fig. 5I,J ; CNPase optical density, control: 440.3 ± 59.7; pooled FCD: 320.6 ± 17.1, P = 0.045; MAG optical density, control: 350.3 ± 21.7; pooled FCD: 303.8 ± 9.9, P = 0.045). Moreover, 3D reconstruction showed that CNPase-and MAG-positive fiber bundles were organized as coherent strands in control cortex (Fig. 5B) , but appeared fractured in FCD (Fig. 5D,F,H) .
Finally, we applied an automated algorithm (see Materials and Methods) to assess whether myelin fibers are reduced in number or size. The total volume of CNPase-and MAG-positive profiles was calculated and found to be nonsignificantly reduced when all FCD types were analyzed separately (Fig. 5K,L) . However, pooled FCD data showed a significant decrease in the total volume of MAG-positive profiles within the respective ROI ( Fig. 5L ; control: 34 130 ± 6190 µm 3 , pooled FCD: 19 180 ± 2922 µm 3 , P = 0.029), whereas the mean volume was not reduced significantly ( Fig. 5N ; control: 8.52 ± 1.20 µm 3 , pooled FCD: 6.93 ± 0.69 µm 3 , P = 0.271). Conversely, the number of reconstructed MAG profiles decreased (Fig. 5P; control: 161.2 ± 31.7, pooled FCD: 75.33 ± 15 .03, P = 0.017), suggesting that the reduction in MAG protein results from a loss in the number of MAG-immunolabeled fibers. elements, the summed volume (L) and the number (P) are significantly reduced for pooled FCD cases, whereas the size of individual profiles is not. WM, white matter. Scale bars: overview 30 µm; (G) (valid also for A, C, and E) 20 µm. Statistical analysis was performed with either Student's t-test or one-way ANOVA. *P < 0.05, **P < 0.01, ns: not significant.
However, the number of reconstructed CNPase-immunoreactive profiles displayed only a nonsignificant decrease (Fig. 5O; control: 233.7 ± 82.6, pooled FCD: 141.4 ± 16.5 , P = 0.104), while the mean volume of these profiles was reduced significantly with a predominance in FCD IIa cases ( Fig. 5M; 
Discussion
The present study is the first whole transcriptome screening of human dysplastic temporal neocortex obtained from surgical specimens removed for therapeutical reasons. We compared the gene expression pattern of FCD IIIa with epileptic nondysplastic controls and found 211 DEX (0.8% of 28 869 genes), excluding X and Y chromosome-located transcripts, among which the majority (171 DEX) was down-regulated. Oligodendrocyte-specific and myelination-associated gene products were one of the dominating functional groups as revealed by DAVID and were altogether down-regulated in dysplastic tissue. In fact, the downregulation of myelin-associated genes was not confined to FCD IIIa, but also a feature present in isolated FCD types (Ia and IIa) as shown on the transcriptional and morphological level. Myelin fibers were heavily disorganized in these FCD types, indicating a defect in axonal ensheathment and myelin maintenance in FCD.
Gene Expression Profile of FCD IIIa
FCD IIIa is defined as a cortical lamination abnormality in the temporal lobe associated with hippocampal sclerosis and is characterized by radial or horizontal disturbances of cortical layering (Blumcke et al. 2011) . Until now, little was known about the molecular mechanisms underlying the pathogenesis of this lesionassociated FCD. Our FCD IIIa patient cohort was characterized by radial hypercolumnization of neurons in layers II-IV and was compared it with an epileptic control group with normal cortical cytoarchitecture. Although both groups were similar with respect to age at surgery (FCD IIIa, mean age 20.5 years; controls, mean age: 19.9 years) and epilepsy duration (FCD IIIa, 11.9 years; controls 8.2 years), PCA showed that the global gene expression profiles of all FCD IIIa specimens and control cases were rather heterogeneous within each group, also reflected by a lack of cluster formation in the PCA plot. The observed heterogeneity is a problem inherent to studies with human brain tissue and cannot be avoided. On the level of individual genes, however, we identified 211 DEX (0.8% of 28 869 genes) by applying a one-way ANOVA, with effect sizes set ≥1.5 and P ≤ 0.05. Since all patients had undergone therapeutic surgery after many years of seizure activity, the observed expression differences (211 DEX) reflect the chronic disease stage. Based on our functional annotation analysis, the FCD-related DEX are involved in biological processes such as neuron and axon ensheathment, regulation of action potential, synaptogenesis, and protein translation. Within these diverse functional groups, the expression values of myelin-associated transcripts displayed the highest fold change [−1.80 to −2.97 and a high enrichment score (1.2) for biological function annotation clustering]. Thus, our whole transcriptome screening suggests that the downregulation of myelin-associated transcripts is a characteristic feature of the FCD IIIa pathology. This assumption is supported by the fact that the expression of myelinationassociated genes was not affected by clinical parameters (gender, age at surgery, epilepsy duration, seizure type, and frequency; see Supplementary Fig. 2B-F) .
Other transcriptome studies focused on seizure-induced gene expression by comparing acutely high-spiking versus nonspiking cortical areas (Arion et al. 2006; Dachet et al. 2015) . In contrast to our study, Arion et al. included gray and white matter derived from the temporal lobe in the transcriptome analysis. They found 76 of 14 500 genes to be differentially expressed. Among those, myelination-associated transcripts were strongly up-regulated, contrasting our results. This contradictory finding may result from the fact that Arion et al. included white matter in their analysis, whereas we focused on dysplastic gray matter. Similarly, Dachet et al. (2015) compared gray matter of acutely high-spiking versus non-spiking cortical areas and identified 2516 differentially expressed transcripts among which 1534 were up-and 982 down-regulated. Transcriptional clustering revealed increased expression of genes specific for endothelial, red and white blood cells, neurons, and microglia, but a decreased expression of oligodendrocyte-specific transcripts in spiking cortical regions. This observation is in line with our findings in FCD IIIa. The higher number of DEX found by Dachet et al. (2015) is most likely due to the fact that acute epileptic activity originating from spiking brain areas may act as a strong transcriptional stimulus (Arion et al. 2006; Beaumont et al. 2012 ). In our study, however, seizure-induced gene expression was excluded since both groups (FCD and controls) were epileptic and, thus, the smaller DEX number detected in our microarray screening may reflect FCD-specific gene regulation. This assumption is supported by the fact that we did not find cAMP-response elementbinding protein element-containing genes that are indicative of highly active brain areas (Beaumont et al. 2012) . It is therefore tempting to speculate that the down-regulation of oligodendrocyte and myelin-specific genes seen in our screening is characteristic for the FCD pathology and not for epilepsy.
There is new evidence that the mechanistic target of rapamycin (mTOR) pathway is involved in the genesis of FCD, since somatic mutations have been found in a subpopulation of FCD type II by sequencing the MTOR gene in FCD IIa tissue (Lim et al. 2015) . We did not detect any mTOR-related genes in our DEX group, except for Dishevelled, Egl-10 and Pleckstrin domain-containing MTOR-interacting protein (DEPTOR). Hence, the genesis of FCD IIIa may be different from isolated FCD type II and/or the pathology involving mTOR is not regulated on the transcriptional level.
Impaired Myelination in FCD Ia, IIa, and IIIa CNP, MOG, MAL, ASPA, UGT8, Opalin, and Ermin encode proteins involved in oligodendrocyte differentiation or myelin sheath formation and maintenance (Baumann and Pham-Dinh 2001; Brockschnieder et al. 2006; Dugas et al. 2006; Cahoy et al. 2008; Swiss et al. 2011 ). We found all these genes to be downregulated in FCD IIIa and validated the decreased transcription of MBP, MOG, MAG, MYRF, and Opalin by real-time RT-qPCR. Moreover, we observed that expression of the abovementioned transcripts was also significantly reduced in FCD Ia and IIa, suggesting that dysregulation of myelin-associated genes is a common feature of FCD pathology. This assumption was supported by our morphological data, showing a reduced density of MBP-expressing oligodendrocytes and of CNPase-positive myelin fibers in the gray matter of FCD Ia, IIa, and IIIa specimens.
MBP is a major component of compact myelin and is synthesized by mature, myelinating oligodendrocytes (Cahoy et al. 2008) that are gradually distributed in the neocortex with the highest density in deeper cortical layers mirrored by the radial arrangement of myelin fibers extending from L VI to the border of L III (Nieuwenhuys 2013; Tomassy et al. 2014) . Accordingly, we observed a gradual distribution of MBP mRNA-expressing oligodendrocytes from L VI towards L II/III in control cortex. In FCD, however, mature oligodendrocytes were thinned out in all cortical layers, in particular in FCD IIa and IIIa. Moreover, we found that the density of radially orientated CNPase-labeled myelin fibers was strongly reduced in FCD Ia, IIa, and IIIa, suggesting a deficit in myelination.
What could be the reason for the observed reduction of mature oligodendrocytes and myelin fibers in FCD? Possibly, the maturation of oligodendrocyte precursor cells into myelinating oligodendrocyte might be disturbed. Oligodendrocyte differentiation is a highly regulated, multistep process including intrinsic (e.g., transcription factors) and extrinsic factors and mechanisms (e.g., neuronal activity; Emery 2010). However, we did not find any changes in the expression of oligodendrocyte precursor markers (e.g., Olig 1, Olig 2, or NG2) in our microarray data arguing against a disturbance in the early differentiation stage. Whether changes in neuronal activity contribute to the observed loss of myelinating oligodendrocytes cannot be answered since our FCD specimens were resected in the chronic epileptic stage. We found, however, a significant downregulation of the transcription factor MYRF, involved in the differentiation of myelinating oligodendrocytes by regulating the transcription of MAG, MOG, and MBP (Koenning et al. 2012; Bujalka et al. 2013) , pointing to an imbalance in the late stage of oligodendrocyte differentiation.
In addition, we found by 3D reconstruction that CNPase-and MAG-immunopositive myelin fibers were fractured and distorted in FCD. The enzyme CNPase is expressed in pre-and mature oligodendrocytes and essential for oligodendrocyte process outgrowth during axon wrapping by interaction with the cytoskeleton (Lee et al. 2005 ). Since we found a reduced size of CNPase-labeled profiles and a downregulation of cytoskeletonassociated transcripts such as GSN, UGT8, and ERMN, it can be assumed that either the oligodendrocyte processes are smaller or axonal integrity is disturbed, as reported earlier for FCD IIb (Shepherd et al. 2013 ). The adhesion protein MAG mediates the interaction between oligodendrocyte and axon, and is therefore important for the formation of intact myelin sheaths (Schachner and Bartsch 2000) . In FCD, we observed a significant decrease in the number of MAG-labeled profiles pointing to a disturbance in glia-axon interaction.
We can exclude that the observed loss of myelin fibers is due to a loss of neurons, since the number of L III and L V NeuN-positive cells is not reduced in FCD (Fauser et al. 2013 ). Altogether it is tempting to speculate that an altered cytoarchitecture of oligodendrocytes could result in an impairment of axon wrapping and in consequence in an incomplete myelination and altered neuronal signal conductance (Arancibia-Carcamo and Attwell 2014). There is recent evidence that hypomyelination of L V neurons results in hyperexcitabilty of the cortical gray matter as shown in a cuprizone mouse model. Demyelination of axons entrains an enhanced intrinsic excitability, which is characterized by increased spontaneous suprathreshold depolarizations as well as antidromically propagating action potentials ectopically generated in distal parts of the axon (Hamada and Kole 2015) . It remains uncertain whether this holds true for our FCD cases and awaits further investigations in appropriate in vitro models.
